Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American Journal of Pathology

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)65508-3PMID 10595919PMCID PMC1866917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors

  1998cited by this paper
• New insights into the tumor suppression function of P27(kip1)

  1998cited by this paper
• Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.

  1998cited by this paper
• Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53.

  1998cited by this paper
• Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.

  1998cited by this paper
• New insights into the tumor suppression function of P27Kip1

  1998cited by this paper
• Cyclin E-CDK2 is a regulator of p27Kip1.

  1997cited by this paper
• Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.

  1996cited by this paper
• Pathology of the major peripheral nerve sheath neoplasms.

  1996cited by this paper
• p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors.

  1996influential reference
• Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

  1995cited by this paper
• Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours

  1995cited by this paper
• Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas.

  1995cited by this paper
• Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

  1995cited by this paper
• Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.

  1995cited by this paper
• Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

  1995cited by this paper
• Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

  1995cited by this paper
• p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

  1995cited by this paper
• Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

  1995cited by this paper
• Role of the cyclin-dependent kinase inhibitors in the development of cancer.

  1995cited by this paper
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

  1994cited by this paper
• Induction of WAF1/CIP1 by a p53-independent pathway.

  1994cited by this paper
• Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

  1994cited by this paper
• p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

  1994cited by this paper
• G1 phase progression: cycling on cue.

  1994cited by this paper
• Identification of G1 kinase activity for cdk6, a novel cyclin D partner

  1994cited by this paper
• Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.

  1994cited by this paper
• pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest

  1994cited by this paper
• TP53 mutations are frequent in malignant NFI tumors

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Physical interaction of the retinoblastoma protein with human D cyclins.

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

  1992cited by this paper
• Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

  1992cited by this paper
• Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases

  1990cited by this paper
• Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.

  1990cited by this paper
• The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity

  1987cited by this paper
• Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases

  1986cited by this paper
• Peripheral nerve sheath tumors: An electron microscopic study of 43 cases

  1982cited by this paper

• WDR12/RAC1 axis promoted proliferation and anti-apoptosis in colorectal cancer cells

  2024cites this paper
• Shaping our understanding of malignant peripheral nerve sheath tumor: a bibliometric analysis of the 100 most-cited articles.

  2024cites this paper
• Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges

  2022cites this paper
• Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo

  2021cites this paper
• Combination therapies for MPNSTs targeting RABL6A-RB1 signaling

  2021cites this paper
• Clinical Significance of Cyclin Expression Profiling in Ocular Surface Squamous Neoplasia

  2021cites this paper
• AXL Inhibition Enhances MEK Inhibitor Sensitivity in Malignant Peripheral Nerve Sheath Tumors

  2020cites this paper
• Prognostic Significance of Immunohistochemical Markers and Genetic Alterations in Malignant Peripheral Nerve Sheath Tumors: A Systematic Review

  2020influential citation
• RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors

  2020influential citation
• CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets

  2020cites this paper
• Angiosarcoma arising in a neurofibromatosis-1 patient as a de novo malignancy?

  2019cites this paper
• The promise of signal transduction in genetically driven sarcomas of the nerve

  2018cites this paper
• Molecular Biology of Human Brain Tumors

  2017cites this paper
• Radiation-Induced Malignant Peripheral Nerve Sheath Tumors: A Systematic Review.

  2017cites this paper
• Oncogenic RAS-MET signal interactions are modulated by P53 status in NF1-related MPNSTs

  2017cites this paper
• Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target

  2017cites this paper
• Malignant Peripheral Nerve Sheath Tumors.

  2016cites this paper
• Prognostic significance of cytoplasmic p27 in oral squamous cell carcinoma.

  2016cites this paper
• Potential of HSP90 Inhibitors to Treat Neurofibromatosis-Related Tumors

  2015cites this paper
• Comparative Oncogenomics for Peripheral Nerve Sheath Cancer Gene Discovery

  2015cites this paper
• A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST.

  2015cites this paper
• Malignant Peripheral Nerve Sheath Tumor (MPNST) Arising in Diffuse-type Neurofibroma: Clinicopathologic Characterization in a Series of 9 Cases

  2015influential citation
• Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis

  2014cites this paper
• Molecular Testing in Bone and Soft Tissue Tumors

  2014cites this paper
• Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis

  2014cites this paper
• Malignant peripheral nerve sheath tumor: pathology and genetics.

  2014cites this paper
• Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.

  2013cites this paper
• The Activation of the WNT Signaling Pathway Is a Hallmark in Neurofibromatosis Type 1 Tumorigenesis

  2013cites this paper
• Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.

  2013cites this paper
• Identification of Genes and Pathways Involved in Schwann Cell Tumor Initiation, Development and Progression to Develop Novel Drug Targets

  2013cites this paper
• Tumeurs du système nerveux périphérique

  2013cites this paper
• Tumori del sistema nervoso periferico

  2013cites this paper
• Elevated expression of IRS2 in the progression from neurofibroma to malignant peripheral nerve sheath tumor.

  2012cites this paper
• Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1

  2012cites this paper
• Cyclin D1 as a Diagnostic Immunomarker for Endometrial Stromal Sarcoma With YWHAE-FAM22 Rearrangement

  2012cites this paper
• MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors.

  2012cites this paper
• Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems

  2012cites this paper
• Neurogenetics: A Guide for Clinicians

  2012cites this paper
• Cell of Origin and the Contribution of Microenvironment in NF1 Tumorigenesis and Therapeutic Implications

  2012cites this paper
• Neurogenic Tumors of Soft Tissue

  2012influential citation
• Intraorbital Isolated Mucocele

  2011cites this paper
• Corticosteroids or Cyclooxygenase 2-Selective Inhibitor Medication for the Management of Pain and Swelling After Third-Molar Surgery

  2011cites this paper
• Patients' Preoperative Expectations and Postoperative Satisfaction of Dysgnathic Patients Operated On With Resorbable Osteosyntheses

  2011cites this paper
• Malignant Peripheral Nerve Sheath Tumor of the Vestibulocochlear Nerve and Brainstem: Multimodality Treatment With Survival of 27 Months. A Case Report and Review of the Literature

  2011cites this paper
• Malignant peripheral nerve sheath tumor of mandible.

  2011cites this paper
• Benign Nodular Hidradenoma of the Face

  2011cites this paper
• Patients' Satisfaction After Surgical Facial Reconstruction or After Rehabilitation With Maxillofacial Prosthesis

  2011cites this paper
• Unexpected Tumor Incidence in Surgically Removed Unilateral and Bilateral Nasal Polyps

  2011cites this paper
• TP53 Mutation Analysis of Malignant Peripheral Nerve Sheath Tumors

  2010cites this paper
• 12 – Peripheral Nerve Sheath Tumors

  2010cites this paper
• Development of Targeted Therapies for Neurofibromatosis Type 1 (NF1) Related Tumors

  2010cites this paper
• Critical role of PTEN for development and progression of nerve sheath tumors in neurofibromatosis type 1.

  2010cites this paper
• Atypical neurofibroma of the skin and subcutaneous tissue: clinicopathologic analysis of 11 cases

  2010cites this paper
• Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors

  2009cites this paper
• Validation of tissue microarray technology in malignant peripheral nerve sheath tumours

  2009cites this paper
• Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways

  2009cites this paper
• Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.

  2009cites this paper
• Surgical Considerations for the Familial Cancer Syndrome, Neurofibromatosis 1: A Comprehensive Review

  2009cites this paper
• Surgical management of neurofibromatosis.

  2009cites this paper
• Neural differenzierte/neuroektodermale Tumoren

  2009cites this paper
• Biomarkers for malignant peripheral nerve sheath tumours.

  2008cites this paper
• Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells

  2008cites this paper
• Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerations

  2008cites this paper
• Fallopian tube malignant mixed müllerian tumor (carcinosarcoma): a case report with immunohistochemical profiling.

  2008cites this paper
• Expression profiles in malignant fibrous histiocytomas: clues for differentiating 'spindle cell' and 'pleomorphic' subtypes.

  2008cites this paper
• Expression of p 27 KIP 1 , p 21 WAF 1 and p 53 does Not Correlate with Prognosis in Node-negative Invasive Ductal Carcinoma of the Breast

  2008cites this paper
• Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1

  2007cites this paper
• Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors

  2007cites this paper
• Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.

  2007cites this paper
• A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.

  2007cites this paper
• Neurofibromatosis 1

  2007cites this paper
• Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.

  2006cites this paper
• Neurofibromatosis 1 and 2

  2006cites this paper
• Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: Relevance of cellularity and p27Kip1

  2006cites this paper
• Practical Genetics

  2006cites this paper
• Expression of p27KIP1, p21WAF1 and p53 does not correlate with prognosis in node-negative invasive ductal carcinoma of the breast.

  2006cites this paper
• Aberrant Expression of the Rb Pathway Proteins in Soft Tissue Sarcomas

  2006cites this paper
• Tumors of the peripheral nerves and plexuses

  2006cites this paper
• New insights in the molecular pathogenesis of neurofibromatosis type 1

  2006cites this paper
• Neurofibromatosis type 1 — a model for nervous system tumour formation?

  2005cites this paper
• Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.

  2005cites this paper
• Diagnosis and treatment options for nerve sheath tumors

  2005cites this paper
• Apolipoprotein D is down-regulated during malignant transformation of neurofibromas.

  2005cites this paper
• Expression Patterns of Cell Cycle Components in Sporadic and Neurofibromatosis Type 1-Related Malignant Peripheral Nerve Sheath Tumors

  2005influential citation
• Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors

  2005influential citation
• DNA Ploidy and Chromosome (FISH) Pattern Analysis of Peripheral Nerve Sheath Tumors

  2004cites this paper
• Tumor Suppressor Mutations and Growth Factor Signaling in the Pathogenesis of NF1‐Associated Peripheral Nerve Sheath Tumors. I. The Role of Tumor Suppressor Mutations

  2004cites this paper
• Peripheral Nervous System Tumors

  2004cites this paper
• Immunohistochemical Expression of p27 and p21 in Canine Cutaneous Mast Cell Tumors and Histiocytomas

  2004cites this paper
• Gene Expression Profiling Reveals Unique Molecular Subtypes of Neurofibromatosis Type I‐associated and Sporadic Malignant Peripheral Nerve Sheath Tumors

  2004cites this paper
• Transcriptional profiling in an MPNST-derived cell line and normal human Schwann cells.

  2004cites this paper
• Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR

  2004cites this paper
• Decreased expression of transforming growth factor-beta II receptor is associated with that of p27KIP1 in giant cell tumor of bone: a possible link between transforming growth factor-beta and cell cycle-related protein.

  2004cites this paper
• Malignant peripheral nerve sheath tumors.

  2004cites this paper
• CD44‐independent hepatocyte growth factor/c‐Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro

  2004cites this paper
• Evidence for involvement of a tumor suppressor gene on 1p in malignant peripheral nerve sheath tumors.

  2003cites this paper
• Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients.

  2003cites this paper
• Molecular genetic alterationsin malignant peripheral nervesheath tumors

  2003cites this paper
• Quantitative RT-PCR reveals a ubiquitous but preferentially neural expression of the KIS gene in rat and human.

  2003cites this paper
• The prognosis in spindle‐cell sarcoma depends on the expression of cyclin‐dependent kinase inhibitor p27Kip1 and cyclin E

  2003cites this paper